Visanne (VI-san, dienogest), a new oral progestin for pelvic pain caused by endometriosis

Women in Canada will be using Visanne (VI-san, dienogest), a new oral progestin for pelvic pain caused by endometriosis.

Endometriosis affects up to 10% of reproductive-age women. It causes pain due to growth of endometrial tissue outside the uterus.

Hormonal treatments help reduce pain by inhibiting the growth of endometrial tissue and suppressing menstruation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote